Literature DB >> 24477727

Transcultural adaptation of the "EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI)" into Brazilian Portuguese.

Erica Vieira Serrano, Valéria Valim, Samira Tatiyama Miyamoto, Raquel Altoé Giovelli, Maurício Aquino Paganotti, Nágela Valadão Cadê.   

Abstract

INTRODUCTION: The EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI) is an index of primary Sjögren's syndrome (PSS) systemic activity.
OBJECTIVE: To perform the ESSDAI transcultural adaptation into Brazilian Portuguese.
METHOD: This was a cross-sectional study with 62 patients with PSS according to the criteria of the 2002 American-European Consensus. Six stages were conducted: conceptual, item, semantic, operational, functional, and measurement equivalences (interobserver reproducibility and construct validity). For the validity assessment, the ESSDAI was compared with the Physician's Global Assessment (PhGA), the Sjögren's Syndrome Disease Activity Index (SSDAI), and the Sjögren's Systemic Clinical Activity Index (SCAI). Patients were classified by a specialist physician into two groups according to disease activity (active and inactive), and according to the intention-to-treat (increase in therapy and no increase in therapy). The ESSDAI was tested in these groups. The following statistical tests were used: intraclass correlation coefficient (ICC), Bland-Altman plot for reproducibility, and Spearman's correlation coefficient (r s) and Mann-Whitney's test for validity (P < 0.05 and 95% CI).
RESULTS: The mean ESSDAI score was 4.95 ± 6.73. The reproducibility obtained a strong ICC of 0.89 and good agreement. When compared with other indices, it showed a strong r s with PhGA (0.83; P < 0.000), a moderate r s with SSDAI (0.658; P < 0.000) and a weak r s with the SCAI (0.411; P = 0.001). The group "active" and the group " increase in therapy" had higher ESSDAI values (P = 0.000).
CONCLUSION: The Brazilian Portuguese version of ESSDAI was shown to be adaptable, reproducible, and valid for this language.

Entities:  

Mesh:

Year:  2013        PMID: 24477727     DOI: 10.1016/j.rbr.2013.04.003

Source DB:  PubMed          Journal:  Rev Bras Reumatol        ISSN: 0482-5004


  6 in total

1.  Transcultural adaptation of the EULAR activity index for primary Sjogren's syndrome in Argentine.

Authors:  Anastasia Secco; Lucila Marino; Natalia Herscovich; Pedro Aicardi; Lorena Techera; Lorena Takashima; María Lida Santiago; Felix Romanini; Marta Mamani; Antonio C Catalán Pellet
Journal:  Eur J Rheumatol       Date:  2019-12-16

2.  Recommendations for evaluation and diagnosis of extra-glandular manifestations of primary sjogren syndrome: results of an epidemiologic systematic review/meta-analysis and a consensus guideline from the Brazilian Society of Rheumatology (articular, pulmonary and renal).

Authors:  Virginia Fernandes Moça Trevisani; Alisson Pugliesi; Sandra Gofinet Pasoto; Maria Lucia Lemos Lopes; Lissiane Karine Noronha Guedes; Samira Tatiyama Miyamoto; Marilena Leal Mesquita Silvestre Fernandes; Sonia Cristina de Magalhães Souza Fialho; Aysa César Pinheiro; Laura Caldas Dos Santos; Simone Appenzeller; Tania Fidelix; Sandra Lúcia Euzébio Ribeiro; Danielle Christinne Soares Egypto de Brito; Tatiana Nayara Libório-Kimura; Maria Carmen Lopes Ferreira Silva Santos; Diego Ustárroz Cantali; Juliana D'Agostino Gennari; Vinicius Tassoni Civile; Ana Carolina Pereira Nunes Pinto; César Ramos Rocha-Filho; Fabiola Reis Oliveira; Aline Pereira da Rocha; Valeria Valim
Journal:  Adv Rheumatol       Date:  2022-06-01

3.  Supervised walking improves cardiorespiratory fitness, exercise tolerance, and fatigue in women with primary Sjögren's syndrome: a randomized-controlled trial.

Authors:  Samira Tatiyama Miyamoto; Valéria Valim; Luciana Carletti; Wan-Fai Ng; Anselmo José Perez; Dennis William Lendrem; Michael Trennel; Raquel Altoé Giovelli; Laiza Hombre Dias; Érica Vieira Serrano; Alice Mendonça Subtil; Vanessa Cândido Abreu; Jamil Natour
Journal:  Rheumatol Int       Date:  2019-01-02       Impact factor: 2.631

4.  Pain and fatigue are predictors of quality of life in primary Sjögren's syndrome.

Authors:  Laiza Hombre Dias; Samira Tatiyama Miyamoto; Raquel Altoé Giovelli; Caerê Iamonde Maciel de Magalhães; Valeria Valim
Journal:  Adv Rheumatol       Date:  2021-05-29

5.  Salivary gland ultrasonography as a predictor of clinical activity in Sjögren's syndrome.

Authors:  Tania Fidelix; Adriano Czapkowski; Sergio Azjen; Adagmar Andriolo; Virginia F M Trevisani
Journal:  PLoS One       Date:  2017-08-04       Impact factor: 3.240

6.  Planned Yellow Fever Primary Vaccination Is Safe and Immunogenic in Patients With Autoimmune Diseases: A Prospective Non-interventional Study.

Authors:  Valéria Valim; Ketty Lysie Libardi Lira Machado; Samira Tatiyama Miyamoto; Arthur Dalmaso Pinto; Priscila Costa Martins Rocha; Erica Vieira Serrano; Valquiria Garcia Dinis; Sônia Alves Gouvêa; João Gabriel Fragoso Dias; Ana Carolina Campi-Azevedo; Andréa Teixeira-Carvalho; Vanessa Peruhype-Magalhães; Ismael Artur da Costa-Rocha; Sheila Maria Barbosa de Lima; Emily Hime Miranda; Gisela Freitas Trindade; Maria de Lourdes de Sousa Maia; Maria Bernadete Renoldi de Oliveira Gavi; Lidia Balarini da Silva; Ruben Horst Duque; Ana Paula Espíndula Gianordoli; Thays Zanon Casagrande; Karine Gadioli Oliveira; Bruna Costa da Mata Moura; Fernanda Nicole-Batista; Luiza Correa Rodrigues; Thalles Brandão Clemente; Enan Sales Magalhães; Maria de Fatima Bissoli; Maria da Penha Gomes Gouvea; Lauro Ferreira da Silva Pinto-Neto; Carolina Zorzanelli Costa; Raquel Altoé Giovelli; Leticia Resende Brandão; Elizandra Tomazela Laurenti Polito; Ingrid de Oliveira Koehlert; Brunela Passos Borjaille; Daniela Bergamim Pereira; Laiza Hombre Dias; Daniela Linhares Merlo; Luiz Fellipe Favoreto Genelhu; Flavia Zon Pretti; Maryella Dos Santos Giacomin; Ana Paula Neves Burian; Francieli Fontana Sutile Tardetti Fantinato; Gecilmara Salviato Pileggi; Lícia Maria Henrique da Mota; Olindo Assis Martins-Filho
Journal:  Front Immunol       Date:  2020-07-17       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.